Shiguang Ye

SIRT1 downregulation enhances chemosensitivity and survival of adult T-cell leukemia-lymphoma cells by reducing DNA double-strand repair

Liang Li, Shiguang Ye, Meng Yang et al. · Oncology Reports · 2015 · 42 citations · Full text

SIRT1 inhibition impairs non-homologous end joining DNA damage repair by increasing Ku70 acetylation in chronic myeloid leukemia cells

Wenjun Zhang, Haixia Wu, Meng Yang et al. · Oncotarget · 2015 · 40 citations · Full text

Immunology, Molecular Biology, Cell Death +20

Risk of HBV Reactivation in Patients With Resolved HBV Infection Receiving Anti-CD19 Chimeric Antigen Receptor T Cell Therapy Without Antiviral Prophylaxis

Ping Li, Lili Zhou, Shiguang Ye et al. · Frontiers in Immunology · 2021 · 24 citations · Full text

Safety and efficacy of a novel anti-CD20 chimeric antigen receptor (CAR)-T cell therapy in relapsed/refractory (r/r) B-cell non-Hodgkin lymphoma (B-NHL) patients after failing CD19 CAR-T therapy.

Aibin Liang, Shiguang Ye, Ping Li et al. · Journal of Clinical Oncology · 2021 · 21 citations

Clinical Immunology, Cell Therapy, Patients Experienced Crs +25

C-CAR039, a Novel Anti-CD20/CD19 Bi-Specific CAR T-Cell Therapy Shows Deep and Durable Clinical Benefits in Patients with Relapsed or Refractory (r/r) B-Cell Non-Hodgkin Lymphoma (B-NHL) in Long Term Follow up

Ping Li, Wenjuan Yu, Lili Zhou et al. · Blood · 2023 · 16 citations